Global Study to Evaluate the Test’s Impact on Treatment Decisions and Outcomes When Therapy Is Directed at a Cancer’s Origin Rosetta Genomics Ltd. , a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, announces the initiation of the Rosetta egistry study , a two-part global registry attempting to evaluate the … (more)
